| Literature DB >> 34920713 |
Xuwei Lu1,2, Chang He1, Sihong Zhang2, Fan Yang1, Zhuifeng Guo1, Jiaqi Huang1, Minke He1, Jiawen Wu1, Xia Sheng3, Wenyao Lin4, Jie Cheng4, Jianming Guo5, Hang Wang6.
Abstract
BACKGROUND: Radical prostatectomy (RP) is the primary treatment of localized prostate cancer. Immediate urinary incontinence post-RP was still common and depressing without specific reason.Entities:
Keywords: Denonvilliers’ fascia; Positive surgical margin; Prostate cancer; Prostatectomy; Urinary continence
Mesh:
Year: 2021 PMID: 34920713 PMCID: PMC8680026 DOI: 10.1186/s12894-021-00943-z
Source DB: PubMed Journal: BMC Urol ISSN: 1471-2490 Impact factor: 2.264
Fig. 1Scenes of Mmi-RRP procedure with DFS technique and pathological section through paramedian of prostate, stained by HE. a DF (white dot line area) kept intact after prostate removal, also shown on schematic drawing (e). b Anterior layer of DF cut open at seminal vesicles triangle level. Dissection was kept between DF and PC towards apex of prostate. Black arrows exhibited the cut-line of DF’s anterior layer. c No DF structure in the backward direction of prostate. d The cut-line of DF on the pathological section (red dot line circle), fused with seminal vesicle fascia propria (black dot line circle). e, f Schematic drawing OF dissecting bladder and prostate junction (green dot line). B: bladder; HE: hematoxylin and eosin; IFT: inter fascial tissue; N: nerve; P: prostate; PB: pubic bone; PC: prostate capsule; R: rectum; SV: seminal vesicles; VD: vas deferens. Black arrow: DF; Black arrow head: PC; White arrow: seminal vesicle fascia propria
Fig. 2Transverse sections at mid-prostate in Group Control (a–d) and Group DFS (f–h), both stained by HE. a Overall vision of pathological section from Group Control. b In 6-o’clock direction of prostate, two layers of DF were dissected with prostate. c In 4-o’clock direction, anterior layer of DF extended anterolaterally alongside with prostate capsule, sometime fused together (show in black dot line circle). Middle layer of DF and NVB were removed with prostate. d Anterior layer of DF extended anterolaterally and connected with levator ani fascia (LAF) at 3-o’clock direction. e Schematic drawing simulated peri-prostate fascia structure including DF and LAF. f Overall vision of pathological section from Group DFS. g In 6-o’clock direction of prostate, few DR fragments without DF layers. h In 8-o’clock direction, DF was spared successfully with no DF structure visible in the specimen. DR: dorsal raphe; DVC: dorsal vascular complex; IFT: inter fascial tissue; LAF: levator ani fascia; N: nerve; P: prostate; PB: pubic bone; R: rectum; V: vessel. Black arrow: DF; Black arrow head: PC; Black rectangle: anterior layer of DF adhered with LAF; Red dot line: cut line of LAF
Demographics and tumor characteristics of patients
| Group DFS (n = 72) | Group Control (n = 82) | ||
|---|---|---|---|
| Mean ± Std (Range) | |||
| Age, years | 67.8 ± 5.0 (58–79) | 69.3 ± 6.5 (54–80) | 0.1 |
| BMI | 24.5 ± 2.6 (17.4–30.9) | 24.5 ± 2.7 (16.8–30.3) | 0.9 |
| Diagnosis PSA, ng/ml | 16.0 ± 12.5 (0.4–61.0) | 38.9 ± 114.7 (4.1–946.6) | 0.1 |
| Prostate volume, ml | 49.2 ± 15.8 (13.5–100.7) | 51.5 ± 18.5 (16.7–122.5) | 0.4 |
| Clinical stage, n (%) | 0.8 | ||
| T1 | 30 (41.7) | 33 (40.2) | |
| T2 | 38 (52.8) | 46 (56.1) | |
| T3 | 4 (5.6) | 3 (3.7) | |
| Diagnosis Gleason, n (%) | 0.2 | ||
| ≤ 6 | 31 (43.1) | 26 (31.7) | |
| 7 | 31 (43.1) | 37 (45.1) | |
| ≥ 8 | 10 (13.9) | 19 (23.2) | |
| Diagnosis method, n (%) | 0.5 | ||
| Biopsy | 66 (91.7) | 78 (95.1) | |
| TURP | 6 (8.3) | 4 (4.9) | |
| IIEF-5 Q2 ≥ 3 pre-surgery, n (%) | 49 (68.1) | 47 (57.3) | 0.2 |
| Comorbid condition, n (%) | |||
| CAD | 9 (12.5) | 10 (12.2) | 1.0 |
| DM | 12 (16.7) | 17 (20.7) | 0.5 |
| HBP | 38 (52.8) | 39 (47.6) | 0.5 |
| COPD | 8 (11.1) | 4 (4.9) | 0.2 |
| CVD | 4 (5.6) | 6 (7.3) | 0.8 |
BMI body mass index, CAD coronary artery disease, COPD chronic obstruction pulmonary diseases, CVD cerebrovascular diseases, DM diabetes mellitus, HBP high blood pressure, TURP transurethral resection of prostate
IIEF-5 Q2: International Index of Erectile Function-5, question NO.2. ‘‘When you had erections with sexual stimulation, how often was your erection hard enough for penetration during the last 3 months?’’ The following responses were available: ‘‘No sexual activity’’ (0); ‘‘Almost never or never’’ (1); ‘‘A few times (much less than half the time)’’ (2); ‘‘Sometimes (about half the time)’’ (3); ‘‘Most times (much more than half the time)’’ (4); and ‘‘Almost always or always’’ (5)
Outcomes of surgery
| Group | DFS, n (%) | Control, n (%) | |
|---|---|---|---|
| Mean ± Std (Range) | |||
| Surgery duration, min | 153.2 ± 66.4 (100–400) | 188.3 ± 65.1 (90–480) | < 0.01 |
| Blood loss, ml | 143.1 ± 107.2 (20–800) | 132.4 ± 136.9 (20–1000) | 0.6 |
| NVB sparing | < 0.01 | ||
| Bilateral | 27 (37.5) | 24 (29.3) | |
| Unilateral | 13 (18.1) | 2 (2.4) | |
| None | 32 (44.4) | 56 (68.3) | |
| LND | 63 (87.5) | 74 (90.2) | 0.6 |
| pT | 0.5 | ||
| T0 | 1 (1.4) | 0 (0) | |
| T2 | 53 (73.6) | 57 (69.5) | |
| T3 | 18 (25.0) | 25 (30.5) | |
| Gleason scores | 0.1 | ||
| 0 | 1 (1.4) | 0 (0) | |
| ≤ 6 | 17 (23.6) | 9 (11) | |
| 7 | 38 (52.8) | 50 (61) | |
| ≥ 8 | 16 (22.2) | 23 (28) | |
| Positive LN | 0 (0) | 3 (3.7) | 0.2 |
| SV invasion | 7 (9.7) | 18 (22) | 0.04 |
| PSM | 15 (20.8) | 17 (20.7) | 1.0 |
| Sites of PSM | 0.3 | ||
| One-site ( | 13 ( | 11 ( | |
| Multiple-sites ( | 2 ( | 6 ( | |
| Post-lateral PSM | 3 (4.2%) | 2 (2.4%) | 0.7 |
| IIEF-5 Q2 ≥ 3 post-surgery | 25 (34.7) | 14 (17.1) | 0.01 |
| Continence | < 0.01 | ||
| Immediate | 60 (83.3) | 11 (13.4) | < 0.01 |
| 3 months- | 65 (90.3) | 25 (30.5) | < 0.01 |
| 6 months- | 66 (91.7) | 53 (64.6) | < 0.01 |
| 12 months- | 67 (93.1) | 66 (80.5) | 0.02 |
LND lymph node dissection, NVB nerve vascular bundle, PSM positive surgical margin, SV seminal vesicles
Fig. 3Kaplan–Meier analysis for time to urinary continence post-surgery
Logistic regression analysis for predictors of immediate continence
| ImC | Univariate | Multi-variate | ||
|---|---|---|---|---|
| Surgery type | < 0.01 | 0.6 | ||
| Mmi-RRP | 13.0 (5.7–29.7) | < 0.01 | 1.9 (0.4–8.7) | 0.4 |
| RARP | 1.2 (0.4–4.0) | 0.7 | 0.8 (0.2–3.6) | 0.7 |
| LND, Yes | 0.7 (0.3–2.0) | 0.6 | ||
| Gleason score | 0.7 (0.5–0.9) | 0.02 | 0.9 (0.5–1.6) | 0.8 |
| SV invasion, Yes | 0.2 (0.1–0.7) | < 0.01 | 0.3 (0.1–1.3) | 0.1 |
| PSM, Yes | 0.9 (0.4–1.9) | 0.8 | ||
| TURP before, Yes | 1.2 (0.3–4.3) | 0.8 | ||
| Diagnosis PSA | 1.0 (0.992–1.003) | 0.4 | ||
| IIEF-5 Q2 pre-surgery | 1.4 (1.0–1.9) | 0.03 | 1.6 (0.9–2.7) | 0.1 |
| Prostate volume | 1.0 (0.98–1.01) | 0.6 | ||
| Age | 1.0 (0.91–1.02) | 0.2 | 1.0 (0.9–1.1) | 0.6 |
| BMI | 0.9 (0.8–1.1) | 0.3 | ||
| Surgery duration | 1.0 (0.98–0.99) | < 0.01 | 1.0 (0.981–1.002) | 0.1 |
| Blood loss | 1.0 (0.996–1.001) | 0.3 | ||
| NVB sparing | 0.01 | 0.9 | ||
| Unilateral vs No | 4.8 (1.4–16.4) | 0.01 | 0.8 (0.1–4.3) | 0.8 |
| Bilateral vs No | 2.1 (1.1–4.3) | 0.04 | 1.1 (0.3–3.8) | 0.9 |
| DF sparing, Yes | 32.3 (13.3–78.4) | < 0.01 | 26.4 (8.4–83. 3) | < 0.01 |
BMI body mass index, CI confidence interval, ImC immediate continence, LND lymph node dissection, NVB nerve vascular bundle, OR odds ratio, PSM positive surgical margin, SV seminal vesicles
Fig. 4Different grades of DFS in RP, stained by hematoxylin and eosin. a In Grade-1 DF sparing procedure, neither DF nor DR was cut with prostate. b In Grade-2 DFS procedure, DF was preserved while DR fragments removed with prostate. c, d In Grade-2 DFS procedure, DF spared successfully while DR was totally cut away. e–f Grade-3 DFS was defined as neither DF nor DR spared. Black arrow head: prostate capsule; Ca: prostate cancer; DR: dorsal raphe (show in blue dot line circle); P: prostate; U: urethra. Black arrow: DF; Black arrow head: PC